Xenter, Inc. is a privately held company headquartered in Salt Lake City, Utah, that is focused on developing new wireless medical device technologies, innovative digital health tools that will enable individual patients to own and manage their health information, and novel therapeutic drugs utilizing Physical Intelligence and patient-supplied data. Xenter has assembled a team of medical scientists, chemical engineers, medical device engineers, researchers, data scientists, and some of the world’s most accomplished entrepreneurs and industry veterans to solve some of the largest challenges in healthcare, medicine and engineering.
Xenter’s founders have collaborated on multiple medical devices and clinical trials in interventional cardiology and structural heart disease. Doctors Elazer R. Edelman, MD, PhD at Harvard/MIT (Boston, MA), William A. Gray, MD at Lankenau Heart Hospital and Main Line Health (Philadelphia, PA), Barry T. Katzen, MD at Baptist Hospital and Miami Cardiac and Vascular Institute (Miami, FL), and Martin B. Leon, MD at Columbia University/New York Presbyterian (New York City, NY) are long time partners working on new medical technologies. Once hearing of the project and the many benefits that it can potentially offer patients around the world, each of them decided to join Rich Linder as the Founding Scientific Board of Xenter, Inc.
Xenter’s exploration and work began in 2017, culminating in a substantial pre-commercial effort beginning early in 2020.